TKI signs its first airline partner as Avelo Airlines commits to the new passenger terminal, marking a milestone amid ...
An airport in a Dallas suburb has secured its first airline partner, Houston-based Avelo Airlines -the same carrier that has ...
At the recent American Society of Hematology annual meeting, researchers presented real-world outcomes for patients with ...
Neoadjuvant TKI therapy in non-metastatic GIST patients can reduce surgical complexity, with CE-CT imaging predicting benefits in 22 of 39 patients. Significant tumor volume reduction was observed ...
A chemotherapy-free-based regimen of the TKI ponatinib combined with targeted immunotherapy showed significant benefits in ...
Treatment with a vascular endothelial growth factor receptor–tyrosine kinase inhibitor (VEGFR–TKI) after previous treatment with checkpoint-inhibitor therapy alone or in combination with a VEGFR–TKI ...
A real-world study demonstrated better survival outcomes when an immunotherapy is combined with a tyrosine kinase inhibitor rather than another immunotherapy therapy for intermediate-risk renal cell ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. OTX-TKI (axitinib intravitreal implant, Ocular ...
LOUISVILLE, Ky. -- Patients with bone-predominant metastatic renal cell carcinoma (RCC) appeared to have better outcomes when they started treatment with a targeted drug, results of a small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback